This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2019 Jun 20;46(6):315-318.

doi: 10.1016/j.jgg.2019.06.001. Epub 2019 Jun 21.

Mutations in TP53, ZNF750, and RB1 typify ocular sebaceous carcinoma

Yongyang Bao¹, J Eva Selfridge², Janet Wang³, Yiqing Zhao³, Junqi Cui¹, Kishore Guda⁴, Zhenghe Wang⁵, Yanbo Zhu⁶

Affiliations

Affiliations

¹ Department of Pathology, The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
² Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, 44106, USA; Case Comprehensive Cancer Center, Cleveland, OH, 44106, USA; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA.
³ Case Comprehensive Cancer Center, Cleveland, OH, 44106, USA; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA.
⁴ Case Comprehensive Cancer Center, Cleveland, OH, 44106, USA. Electronic address: gkishore@yahoo.com.
⁵ Case Comprehensive Cancer Center, Cleveland, OH, 44106, USA; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA. Electronic address: zxw22@case.edu.
⁶ Department of Pathology, The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China. Electronic address: zhuyb72@163.com.

PMID: 31278009
DOI: 10.1016/j.jgg.2019.06.001

Mutations in TP53, ZNF750, and RB1 typify ocular sebaceous carcinoma

Yongyang Bao et al. J Genet Genomics. 2019.

. 2019 Jun 20;46(6):315-318.

doi: 10.1016/j.jgg.2019.06.001. Epub 2019 Jun 21.

Authors

Yongyang Bao¹, J Eva Selfridge², Janet Wang³, Yiqing Zhao³, Junqi Cui¹, Kishore Guda⁴, Zhenghe Wang⁵, Yanbo Zhu⁶

Affiliations

¹ Department of Pathology, The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
² Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, 44106, USA; Case Comprehensive Cancer Center, Cleveland, OH, 44106, USA; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA.
³ Case Comprehensive Cancer Center, Cleveland, OH, 44106, USA; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA.
⁴ Case Comprehensive Cancer Center, Cleveland, OH, 44106, USA. Electronic address: gkishore@yahoo.com.
⁵ Case Comprehensive Cancer Center, Cleveland, OH, 44106, USA; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA. Electronic address: zxw22@case.edu.
⁶ Department of Pathology, The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China. Electronic address: zhuyb72@163.com.

PMID: 31278009
DOI: 10.1016/j.jgg.2019.06.001

No abstract available

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal